Publications — Peer-Reviewed Microbiome Research

2018

  • July 2018 Gut Microbial Beta-Glucuronidase Inhibition via Catalytic Cycle Interception
  • May 2018 Microbial Glucuronidase Inhibition Reduces Severity of Diclofenac-Induced Anastomotic Leak
  • January 2018 Structural Basis for the Regulation of Beta-Glucuronidase Expression by Human Gut Enterobacteriaceae

2017

  • July 2017 An Atlas of Beta-Glucuronidases in the Human Intestinal Microbiome
  • February 2017 Review: Microbial Molecules from the Multitudes within Us

2015

  • December 2015 Structure and Inhibition of Microbiome Beta-Glucuronidases

2014

  • January 2014 Beta-Glucuronidase Inhibition Protects Mice Against NSAID-Induced Enteropathy

2013

  • August 2013 Molecular Insights into Microbial Beta-Glucuronidase Inhibition to Abrogate CPT-11 Toxicity
  • June 2013 The Human Microbiome is a Source of Therapeutic Drug Targets

2012

  • May 2012 Pharmacologic Targeting of Bacterial Beta-Glucuronidase Alleviates NSAID-Induced Enteropathy

2010

  • November 2010 Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme

Symberix, Inc. 4819 Emperor Blvd, #400 Durham, NC 27703

Icons by icons8 .

Connect with Symberix

Learn more about our science, pipeline, or partnership opportunities.

Contact us